Zobrazeno 1 - 10
of 275
pro vyhledávání: '"Robert J Volk"'
Autor:
Cassandra Calabrese, Maria E Suarez-Almazor, Robert J Volk, Adi Diab, Mehmet Altan, Viola B Leal, Maria A Lopez-Olivo, Gabrielle F Duhon, McKenna Erck, Hussain Tawbi, Alexa Meara, Clifton Bingham
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/4a2a4a71e9834a0d914be351629d575c
Autor:
Maria A Lopez-Olivo, Gaurav Sharma, Gagandeep Singh, Justin James, Kate J Krause, Paul Cinciripini, Robert J Volk, Maria E Suarez-Almazor
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0279065 (2022)
ObjectiveSmoking rates among patients with rheumatoid arthritis (RA) exceed those in the general population. This study identified smoking cessation strategies used in patients with RA and synthesized data on their effects.MethodsWe conducted a syste
Externí odkaz:
https://doaj.org/article/53ad696202bb4cc4aaf712f9974cbcd4
Autor:
Cai Xu, Grace L Smith, Ying-Shiuan Chen, Cristina M Checka, Sharon H Giordano, Kelsey Kaiser, Lisa M Lowenstein, Hilary Ma, Tito R Mendoza, Susan K Peterson, Ya-Chen T Shih, Sanjay Shete, Chad Tang, Robert J Volk, Chris Sidey-Gibbons
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272804 (2022)
ObjectivesThis study sought to evaluate advanced psychometric properties of the 15-item Economic Strain and Resilience in Cancer (ENRICh) measure of financial toxicity for cancer patients.MethodsWe surveyed 515 cancer patients in the greater Houston
Externí odkaz:
https://doaj.org/article/d9663e29517a4df8a863491ac063b29e
Publikováno v:
BMJ Open, Vol 11, Iss 11 (2021)
Objective Little is known about clinicians’ decision-making about decreasing active surveillance (AS) testing/converting patients to watchful waiting (WW), nor are there any guidelines. The objective of this study was to identify factors that clini
Externí odkaz:
https://doaj.org/article/d1c3e451e0324792843db5e8eb116fca
Autor:
Patrick Gavin, Lisa M Lowenstein, Robert J Volk, Amanda Cuddy, Andrea P Hempstead, Y Nancy You, Katherine Van Loon, Stefanos Millas, Jeffrey A Meyerhardt, George J Chang
Publikováno v:
BMJ Open, Vol 9, Iss 8 (2019)
ObjectiveWe sought to determine patients’ informational needs for post-treatment surveillance and elicit clinicians’ and patient advocates’ (ie, stakeholders) opinions regarding what patients should know about post-treatment surveillance in the
Externí odkaz:
https://doaj.org/article/76131ef3a5cd406298123e19428603c4
Why men with a low-risk prostate cancer select and stay on active surveillance: A qualitative study.
Autor:
Aaron T Seaman, Kathryn L Taylor, Kimberly Davis, Kenneth G Nepple, John H Lynch, Anthony D Oberle, Ingrid J Hall, Robert J Volk, Heather Schacht Reisinger, Richard M Hoffman
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0225134 (2019)
ObjectiveActive surveillance (AS) is an increasingly utilized strategy for monitoring men with low-risk prostate cancer (PCa) that allows them to defer active treatment (AT) in the absence of cancer progression. Studies have explored reasons for sele
Externí odkaz:
https://doaj.org/article/09afd402e2064e7ba1c9ef31e36480b5
Autor:
Daniel D. Joyce, Jon C. Tilburt, Joel E. Pacyna, Kristin Cina, Daniel G. Petereit, Kathryn R. Koller, Christie A. Flanagan, Barbara Stillwater, Mariam Miller, Judith S. Kaur, Elizabeth Peil, David Zahrieh, Amylou C. Dueck, Victor M. Montori, Dominick L. Frosch, Robert J. Volk, Simon P. Kim
Publikováno v:
Urology. 175:90-95
Publikováno v:
Annals of Internal Medicine. 176:718-720
Publikováno v:
Patient Education and Counseling. 106:17-30
To summarize how Asian Americans negotiate involvement in shared decision-making (SDM) with their providers, the cultural influences on SDM, and perceived barriers and facilitators to SDM.This is a systematic review of qualitative studies. We searche
Autor:
Maria A. Lopez-Olivo, Gabrielle F. Duhon, Juan I. Ruiz, Mehmet Altan, Hussein Tawbi, Adi Diab, Clifton O. Bingham, Cassandra Calabrese, Natalia I. Heredia, Robert J. Volk, Maria E. Suarez-Almazor
Publikováno v:
Cancers; Volume 15; Issue 10; Pages: 2690
Immune checkpoint inhibitors (ICIs) have improved cancer outcomes but can cause severe immune-related adverse events (irAEs) and flares of autoimmune conditions in cancer patients with pre-existing autoimmune disease. The objective of this study was